CO-DIAGNOSTICS INC's ticker is CODX and the CUSIP is 189763105. A total of 85 filers reported holding CO-DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,275 | -4.5% | 3,090 | 0.0% | 0.00% | – |
| Q2 2023 | $3,430 | -25.0% | 3,090 | 0.0% | 0.00% | – |
| Q1 2023 | $4,573 | +2928.5% | 3,090 | +5050.0% | 0.00% | – |
| Q4 2022 | $151 | -99.9% | 60 | 0.0% | 0.00% | – |
| Q3 2022 | $193,000 | -42.7% | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $337,000 | -9.2% | 60 | 0.0% | 0.00% | – |
| Q1 2022 | $371,000 | -30.8% | 60 | 0.0% | 0.00% | – |
| Q4 2021 | $536,000 | -74.0% | 60 | -71.7% | 0.00% | – |
| Q3 2021 | $2,063,000 | -87.3% | 212 | -89.3% | 0.00% | – |
| Q2 2021 | $16,302,000 | -56.2% | 1,976 | -49.3% | 0.00% | – |
| Q1 2021 | $37,196,000 | -43.3% | 3,899 | -44.7% | 0.00% | – |
| Q4 2020 | $65,621,000 | -91.4% | 7,056 | -87.4% | 0.00% | -100.0% |
| Q3 2020 | $763,989,000 | +3962.0% | 56,217 | +5683.6% | 0.00% | – |
| Q2 2020 | $18,808,000 | – | 972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Koss-Olinger Consulting, LLC | 111,808 | $119,000 | 0.02% |
| Physician Wealth Advisors, Inc. | 39,375 | $40,950 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 272,900 | $289,274 | 0.01% |
| Aristides Capital LLC | 15,000 | $15,900 | 0.01% |
| XTX Topco Ltd | 21,763 | $23,069 | 0.00% |
| Portside Wealth Group, LLC | 12,000 | $13,000 | 0.00% |
| Engineers Gate Manager LP | 13,309 | $14,108 | 0.00% |
| Renaissance Technologies | 636,400 | $675 | 0.00% |
| Kestra Advisory Services, LLC | 128,560 | $136,274 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 4,000 | $4,240 | 0.00% |